Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

1.59USD
2:21pm EDT
Price Change (% chg)

$-0.01 (-0.62%)
Prev Close
$1.60
Open
$1.60
Day's High
$1.60
Day's Low
$1.58
Volume
3,318
Avg. Vol
53,423
52-wk High
$2.41
52-wk Low
$0.95

ATHX.OQ

Chart for ATHX.OQ

About

Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being... (more)

Overall

Beta: 1.63
Market Cap (Mil.): $90.09
Shares Outstanding (Mil.): 56.30
Dividend: --
Yield (%): --

Financials

  ATHX.OQ Industry Sector
P/E (TTM): -- 44.65 37.87
EPS (TTM): -0.49 -- --
ROI: -127.66 -2.30 18.70
ROE: -188.28 -2.12 19.53
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$460.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks